Breaking News Instant updates and real-time market news.

2022-12-09 09:45:00 09:45 12/09/22 12/09 09:45 12/09/22 09:45	Jefferies aerospace/defense analysts to hold analyst/industry conference call Aerospace & Defense/Airlines Analysts Kahyaoglu and Lemarie provide a weekly industry update on an Analyst/Industry conference call to be held on December 9 at 10 am. Webcast Link

2022-12-09 09:45:00

09:45

12/09/22

12/09

09:45

12/09/22

09:45

Jefferies aerospace/defense analysts to hold analyst/industry conference call

Aerospace & Defense/Airlines Analysts Kahyaoglu and Lemarie provide a weekly industry update on an Analyst/Industry conference call to be held on December 9 at 10 am. Webcast Link

OTHER BREAKING NEWS FROM THE FLY

Initiation	Zimmer Biomet initiated with a Sell at UBS » 08:39 03/29/23 03/29 08:39 03/29/23 08:39 ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 01/05/23 Zimmer Biomet to acquire Embody for $155M at closing 11/30/22 NeuroOne Medical ships initial Zimmer Biomet order for Evo sEEG system 11/21/22 Zimmer Biomet announces FDA 510(k) clearance of Persona OsseoTi Keel Tibia 11/05/22 Zimmer Biomet announces one-year data from mymobility clinical study ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 03/28/23 UBS Zimmer Biomet initiated with a Sell at UBS 03/10/23 Piper Sandler Zimmer upgraded to Overweight on 'conservative' outlook at Piper Sandler 03/09/23 Piper Sandler Zimmer Biomet upgraded to Overweight from Neutral at Piper Sandler 02/06/23 Loop Capital Zimmer Biomet price target raised to $140 from $125 at Loop Capital ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 02/03/23 Zimmer Biomet sees FY23 adjusted EPS $6.95-$7.15, consensus $6.98 02/03/23 Zimmer Biomet reports Q4 EPS $1.88, consensus $1.83 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 03/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/03/23 What You Missed On Wall Street This Morning 01/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Downgrade	Ross Stores downgraded to Sell at UBS on softlines bearishness » 08:39 03/29/23 03/29 08:39 03/29/23 08:39 ROST Ross Stores $103.12 / +2.51 (+2.49%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ROST Ross Stores $103.12 / +2.51 (+2.49%) 11/17/22 Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised 11/14/22 Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3 10/16/22 Fly Intel: Top five weekend stock stories ROST Ross Stores $103.12 / +2.51 (+2.49%) 06:18 Today UBS Ross Stores downgraded to Sell from Neutral at UBS 03/22/23 Loop Capital Loop upgrades Ross Stores to Buy on steady spending, conservative outlook 03/22/23 Loop Capital Ross Stores upgraded to Buy from Hold at Loop Capital 03/01/23 Deutsche Bank Ross Stores price target lowered to $120 from $121 at Deutsche Bank ROST Ross Stores $103.12 / +2.51 (+2.49%) 02/28/23 Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09 02/28/23 Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18 02/28/23 Ross Stores reports Q4 EPS $1.31, consensus $1.24 02/28/23 Notable companies reporting after market close ROST Ross Stores $103.12 / +2.51 (+2.49%) 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says ROST Ross Stores $103.12 / +2.51 (+2.49%) 03/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/23 Fly Intel: After-Hours Movers 11/18/22 What You Missed On Wall Street On Friday 11/18/22 What You Missed On Wall Street This Morning ROST Ross Stores $103.12 / +2.51 (+2.49%) 03/22/23 Early notable gainers among liquid option names on March 22nd 11/28/22 Ross Stores put volume heavy and directionally bearish 11/18/22 Early notable gainers among liquid option names on November 18th 11/17/22 Ross Stores options imply 4.9% move in share price post-earnings
Earnings	Paychex sees FY23 EPS growth of of 13%-14%, consensu $4.24 » 08:39 03/29/23 03/29 08:39 03/29/23 08:39 PAYX Paychex $108.88 / -0.1 (-0.09%) The company's … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PAYX Paychex $108.88 / -0.1 (-0.09%) 01/24/23 Paychex appoints Theresa Payton to Board of Directors 12/28/22 Paychex VP Gioja sells $1.6M in company shares 12/11/22 Fly Intel: Top five weekend stock stories 10/14/22 Paychex names President and CEO John Gibson, Jr. to board PAYX Paychex $108.88 / -0.1 (-0.09%) 03/13/23 Barclays Paychex price target lowered to $105 from $110 at Barclays 01/17/23 Barclays Paychex downgraded to Underweight from Equal Weight at Barclays 01/03/23 Deutsche Bank Paychex price target lowered to $116 from $123 at Deutsche Bank 12/27/22 Evercore ISI Paychex price target lowered to $114 from $117 at Evercore ISI PAYX Paychex $108.88 / -0.1 (-0.09%) 08:36 Today Paychex reports Q3 EPS $1.29, consensus $1.24 03/28/23 Notable companies reporting before tomorrow's open 03/28/23 Notable companies reporting before tomorrow's open 12/22/22 Paychex raises FY23 adjusted EPS view to up 12%-14% from up 11%-12% PAYX Paychex $108.88 / -0.1 (-0.09%) 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says PAYX Paychex $108.88 / -0.1 (-0.09%) 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 09:30 Today Paychex - PAYX
Downgrade	Bath & Body Works downgraded to Neutral at UBS on softlines bearishness » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/06/23 Bath & Body Works announces appointment of Kuhn to board of directors 02/27/23 Bath & Body Works calls Third Point's potential proxy contest 'misguided' 02/23/23 Bath & Body Works taking enterprise-wide effort to reduce expenses 02/23/23 Bath & Body Works responds to Third Point intent to nominate board candidates BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 06:19 Today UBS Bath & Body Works downgraded to Neutral from Buy at UBS 03/23/23 Piper Sandler Bath & Body Works price target lowered to $48 from $52 at Piper Sandler 03/17/23 Argus Bath & Body Works cut to Hold at Argus on online competition, slowing sales 03/17/23 Argus Bath & Body Works downgraded to Hold from Buy at Argus BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 02/23/23 Bath & Body Works sees FY23 cont ops EPS $2.50-$3.00, consensus $3.16 02/23/23 Bath & Body Works sees Q1 cont ops EPS 17c-27c, consensus 44c 02/23/23 Bath & Body Works reports Q4 cont ops EPS $1.86, consensus $1.62 02/22/23 Notable companies reporting before tomorrow's open BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 02/22/23 Third Point plans proxy fight at Bath & Body Works, WSJ reports 02/22/23 Third Point plans proxy fight at Bath & Body Works, WSJ reports BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 Fly Intel: Pre-market Movers 02/22/23 What You Missed On Wall Street On Wednesday 02/15/23 What You Missed On Wall Street On Wednesday BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/28/23 Early notable gainers among liquid option names on March 28th 03/22/23 Early notable gainers among liquid option names on March 22nd 02/16/23 Bath & Body Works call volume above normal and directionally bullish 02/01/23 Bath & Body Works call volume above normal and directionally bullish
Initiation	Inspire Medical initiated with a Buy at UBS » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 INSP Inspire Medical $238.42 / -9.82 (-3.96%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $238.42 / -9.82 (-3.96%) 03/21/23 Inspire Medical announces FDA approval for pediatric patients with Down Syndrome 03/09/23 Inspire Medical receives countrywide reimbursement approval in Belgium 12/20/22 Inspire Medical publishes inaugural ESG summary report INSP Inspire Medical $238.42 / -9.82 (-3.96%) 03/28/23 UBS Inspire Medical initiated with a Buy at UBS 02/08/23 Lake Street Inspire Medical price target raised to $305 from $250 at Lake Street 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler INSP Inspire Medical $238.42 / -9.82 (-3.96%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $238.42 / -9.82 (-3.96%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/23 Inspire Medical Systems, Inc.
Recommendations	Biomea Fusion price target raised to $47 from $25 at Oppenheimer » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) Oppenheimer raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion trading resumes 03/28/23 Biomea Fusion trading halted, volatility trading pause 03/28/23 Biomea Fusion announces data from ongoing Phase II study of BMF-219 01/17/23 Biomea Fusion doses first patient in COVALENT-102 trial of BMF-219 BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 06:06 Today Citi Biomea Fusion price target raised to $60 from $20 at Citi 03/28/23 H.C. Wainwright Biomea Fusion price target raised to $44 from $37 at H.C. Wainwright 03/28/23 Piper Sandler Biomea Fusion price target raised to $40 from $16 at Piper Sandler 02/24/23 Citi Biomea Fusion initiated with a Buy at Citi BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion reports Q4 EPS (21c), consensus (81c) 11/07/22 Biomea Fusion reports Q3 EPS (78c), consensus (65c) 30 Mar BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion options imply 11.3% move in share price post-earnings
Earnings	Cintas reports Q4 EPS $3.14, consensus $3.04 » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 CTAS Cintas $443.89 / +3.48 (+0.79%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CTAS Cintas $443.89 / +3.48 (+0.79%) 12/16/22 Cintas launches electric vehicle pilot program 11/15/22 Cintas expands cleanroom footprint with new facility in New York CTAS Cintas $443.89 / +3.48 (+0.79%) 12/22/22 Wells Fargo Cintas price target raised to $450 from $393 at Wells Fargo 12/22/22 Deutsche Bank Cintas price target raised to $507 from $490 at Deutsche Bank 12/22/22 Baird Cintas price target raised to $500 from $475 at Baird 12/22/22 Morgan Stanley Cintas price target raised to $401 from $373 at Morgan Stanley CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65 12/21/22 Cintas reports Q2 EPS $3.12, consensus $3.03 CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 What You Missed On Wall Street On Wednesday 12/21/22 What You Missed On Wall Street This Morning 10:00 Today Cintas - CTAS
Hot Stocks	Taoping enters long-term strategic cooperation agreement with Zhaoyuan City » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 TAOP Taoping / + Taoping has entered into… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News TAOP Taoping / + 03/17/23 Taoping receives Nasdaq minimum bid price requirement extension 11/17/22 Taoping signs three-year strategic cooperation agreement with ZhongShengShi Co. 11/09/22 Taoping signs three-year cooperation agreement with DoWatch Technology 10/18/22 Taoping enters into strategic cooperation with Jiangsu SuLiXin
Hot Stocks	BK Technologies receives $781K order for KNG Series mobile radios » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 BKTI BK Technologies $2.98 / -0.15 (-4.79%) BK Technologies received… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BKTI BK Technologies $2.98 / -0.15 (-4.79%) 03/16/23 BK Technologies board decides to suspend quarterly cash dividend 03/09/23 BK Technologies receives purchase order for InteropONE PTToC service 03/08/23 WidePoint signs reseller agreement with BK Technologies 03/08/23 BK Technologies signs reseller agreement with WidePoint BKTI BK Technologies $2.98 / -0.15 (-4.79%) 09/19/22 ThinkEquity BK Technologies initiated with a Buy at ThinkEquity BKTI BK Technologies $2.98 / -0.15 (-4.79%) 03/16/23 BK Technologies reports Q4 EPS (6c) vs. (2c) last year 11/03/22 BK Technologies reports Q3 EPS (14c) vs. (15c) last year
Initiation	Boston Scientific initiated with a Buy at UBS » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 BSX Boston Scientific $48.60 / +0.265 (+0.55%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BSX Boston Scientific $48.60 / +0.265 (+0.55%) 01/11/23 Boston Scientific targeting 'double digit' EPS growth in 2023, consensus $1.93 12/11/22 Fly Intel: Top five weekend stock stories 12/11/22 Boston Scientific to acquire majority stake of Acotec Scientific 11/29/22 Apollo Endosurgery to be acquired by Boston Scientific for $10.00 per share BSX Boston Scientific $48.60 / +0.265 (+0.55%) 03/28/23 UBS Boston Scientific initiated with a Buy at UBS 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 02/17/23 Argus Boston Scientific price target raised to $55 from $50 at Argus 02/02/23 Needham Boston Scientific price target raised to $53 from $48 at Needham BSX Boston Scientific $48.60 / +0.265 (+0.55%) 02/01/23 Boston Scientific sees FY23 adjusted EPS $1.86-$1.93, consensus $1.93 02/01/23 Boston Scientific sees Q1 adjusted EPS 42c-44c, consensus 44c 02/01/23 Boston Scientific reports Q4 adjusted EPS 45c, consensus 47c 01/31/23 Notable companies reporting before tomorrow's open BSX Boston Scientific $48.60 / +0.265 (+0.55%) 12/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/29/22 What You Missed On Wall Street On Tuesday 11/29/22 What You Missed On Wall Street This Morning 10/26/22 What You Missed On Wall Street This Morning 05/04/23 Boston Scientific Corporation BSX Boston Scientific $48.60 / +0.265 (+0.55%) 01/11/23 Boston Scientific put volume heavy and directionally bearish

Hot Stocks	CytoSorbents announces study on CytoSorb hemoperfusion » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 CTSO CytoSorbents $3.39 / +0.055 (+1.65%) CytoSorbents highlights… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 03/22/23 CytoSorbents highlights new data to prevent endothelial damage to blood vessels 03/14/23 CytoSorbents reports no direct exposure to SVB, Signature Bank 03/07/23 CytoSorbents announces new European guidelines that consider hemoadsorption 01/23/23 CytoSorbents' STAR-T trial receives Health Canada regulatory approval CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 05/04/22 B. Riley CytoSorbents price target lowered to $6 from $7 at B. Riley CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 03/09/23 CytoSorbents reports Q4 revenue $9.4M, consensus $8.72M 01/31/23 CytoSorbents sees Q4 revenue $9.4M, consensus $8.9M 11/03/22 CytoSorbents reports Q3 EPS (28c), consensus (16c)
Hot Stocks	Foretell Reality partners with UMD Robert H. Smith School of Business » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 VRAR Glimpse Group $3.64 / -0.04 (-1.09%) The Glimpse Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 03/22/23 QReal enters contractto develop AR experience for Denny's 02/27/23 Brightline Interactive signs CRADA with U.S. NSWCDD 02/21/23 PulpoAR announces Fingernail Segmentation, Skin Diagnostics integration 02/09/23 Glimpse Israel selected by Israeli Ministry of Education as key partner VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 12/19/22 EF Hutton Glimpse Group assumed with a Buy at EF Hutton VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 02/14/23 Glimpse Group options imply 13.9% move in share price post-earnings
Earnings	Paychex reports Q3 EPS $1.29, consensus $1.24 » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 PAYX Paychex $108.88 / -0.1 (-0.09%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PAYX Paychex $108.88 / -0.1 (-0.09%) 01/24/23 Paychex appoints Theresa Payton to Board of Directors 12/28/22 Paychex VP Gioja sells $1.6M in company shares 12/11/22 Fly Intel: Top five weekend stock stories 10/14/22 Paychex names President and CEO John Gibson, Jr. to board PAYX Paychex $108.88 / -0.1 (-0.09%) 03/13/23 Barclays Paychex price target lowered to $105 from $110 at Barclays 01/17/23 Barclays Paychex downgraded to Underweight from Equal Weight at Barclays 01/03/23 Deutsche Bank Paychex price target lowered to $116 from $123 at Deutsche Bank 12/27/22 Evercore ISI Paychex price target lowered to $114 from $117 at Evercore ISI PAYX Paychex $108.88 / -0.1 (-0.09%) 03/28/23 Notable companies reporting before tomorrow's open 03/28/23 Notable companies reporting before tomorrow's open 12/22/22 Paychex raises FY23 adjusted EPS view to up 12%-14% from up 11%-12% 12/22/22 Paychex reports Q2 adjusted EPS 99c, consensus 95c PAYX Paychex $108.88 / -0.1 (-0.09%) 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says PAYX Paychex $108.88 / -0.1 (-0.09%) 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 09:30 Today Paychex - PAYX
Initiation	Craig-Hallum bullish on Gambling.com, initiates with a Buy » 08:35 03/29/23 03/29 08:35 03/29/23 08:35 GAMB Gambling.com $9.51 / -0.22 (-2.26%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/08/23 Gambling.com ready to launch online sports betting in MA with BetMassachusetts 02/08/23 Gannett sees strategic partnership with Gambling.com as immediately accretive GAMB Gambling.com $9.51 / -0.22 (-2.26%) 07:20 Today Craig-Hallum Gambling.com initiated with a Buy at Craig-Hallum 11/18/22 Stifel Gambling.com price target raised to $12 at Stifel after 'solid' Q3 10/25/22 Truist Gambling.com price target raised to $12 from $10.50 at Truist 08/30/22 Truist Gambling.com price target lowered to $10.50 from $12 at Truist GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/23/23 Gambling.com reports Q4 adjusted EPS 2c, consensus 2c 11/17/22 Gambling.com backs FY22 revenue $71M-$76M, consensus $71M 11/17/22 Gambling.com reports Q3 adjusted EPS 16c, two estimates 5c GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/24/23 Bet On It: New York weekly wagering numbers see March Madness bump 11/17/22 Fly Intel: After-Hours Movers GAMB Gambling.com $9.51 / -0.22 (-2.26%) 10/19/22 Twelve new option listings and two option delistings on October 19th
Initiation	Insulet initiated with a Neutral at UBS » 08:35 03/29/23 03/29 08:35 03/29/23 08:35 PODD Insulet $311.43 / -3.26 (-1.04%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly PODD Insulet $311.43 / -3.26 (-1.04%) 03/15/23 Insulet to replace SVB Financial in S&P 500 at open on 3/15 03/10/23 Insulet to replace SVB Financial in S&P 500 at open on 3/15 03/10/23 Insulet to replace SVB Financial in S&P 500 02/14/23 Insulet acquires assets of Automated Glucose Control for $25M PODD Insulet $311.43 / -3.26 (-1.04%) 03/28/23 UBS Insulet initiated with a Neutral at UBS 02/24/23 Raymond James Insulet price target raised to $334 from $320 at Raymond James 02/24/23 Baird Insulet price target raised to $350 from $340 at Baird 02/24/23 Barclays Insulet price target raised to $292 from $245 at Barclays PODD Insulet $311.43 / -3.26 (-1.04%) 02/23/23 Insulet sees FY23 revenue growth 14%-19%, consensus $1.47B 02/23/23 Insulet sees Q1 revenue growth 11%-14%, consensus $333.86M 02/23/23 Insulet reports Q4 adjusted EPS 55c, consensus 21c 11/03/22 Insulet raises FY22 revenue growth view to 18%-19% from 14%-17% PODD Insulet $311.43 / -3.26 (-1.04%) 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports PODD Insulet $311.43 / -3.26 (-1.04%) 02/23/23 Fly Intel: After-Hours Movers 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 10/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Earnings	IM Cannabis reports Q4 EPS ($1.28) vs. (19c) last year » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 IMCC IM Cannabis / + Reports Q4 continuing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research IMCC IM Cannabis / + 10/12/22 Avant Brands, IM Cannabis launch BLKMKT in Israel 10/12/22 Avant Brands, IM Cannabis announce the launch of BLK MKT in Israel IMCC IM Cannabis / + 08/16/22 Alliance Global Partners IM Cannabis price target lowered to $1.50 from $6 at Alliance Global Partners
Hot Stocks	Global Tech Industries updates shareholders on contact with FINRA » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 GTII Global Tech Industries $2.32 / +0.085 (+3.80%) Global Tech Industries… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News GTII Global Tech Industries $2.32 / +0.085 (+3.80%) 02/24/23 Creatd terminates discussions with Global Tech on proposed acquisition 01/23/23 Global Tech appoints Donald Gilbert to lead illegal trading task force 01/10/23 Global Tech Industries executes binding LOI for Creatd acquisition 12/06/22 Global Tech retains ShareIntel-Shareholder to assist Christian Levine Law
Hot Stocks	Nikola says has received orders for 100 Class 8 FCEVs » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 NKLA Nikola $1.48 / -0.045 (-2.96%) Nikola announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NKLA Nikola $1.48 / -0.045 (-2.96%) 03/27/23 Nikola CFO Kim Brady to retire, Anastasiya Pasterick to succeed 03/16/23 Nikola says battery manufacturing move to Arizona ahead of schedule 02/23/23 Nikola provides 2023 outlook 02/22/23 Nikola, E.ON and Richter Group sign collaboration agreement NKLA Nikola $1.48 / -0.045 (-2.96%) 03/13/23 Morgan Stanley Nikola initiated with an Equal Weight at Morgan Stanley 02/24/23 Deutsche Bank Nikola price target lowered to $3 from $5 at Deutsche Bank 02/24/23 Cowen Nikola price target lowered to $5 from $10 at Cowen 01/17/23 BTIG Nikola price target lowered to $5 from $7 at BTIG NKLA Nikola $1.48 / -0.045 (-2.96%) 02/23/23 Nikola reports Q4 adjusted EPS (37c), consensus (43c) 02/22/23 Notable companies reporting before tomorrow's open 02/22/23 Notable companies reporting before tomorrow's open 11/03/22 Nikola reports Q3 adjusted EPS (28c), consensus (39c) NKLA Nikola $1.48 / -0.045 (-2.96%) 01/20/23 Nikola speculated by The Deal as 'attractive' to activist 12/01/22 Fuzzy Panda short Fisker, says 'asset-light' model really 'liability-heavy' 10/14/22 Nikola founder Milton found guilty in criminal fraud trial, Bloomberg says 10/14/22 Jury reaches verdict in Nikola founder criminal fraud trial, Bloomberg says NKLA Nikola $1.48 / -0.045 (-2.96%) 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning 03/13/23 What You Missed This Week in EVs and Clean Energy 03/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations NKLA Nikola $1.48 / -0.045 (-2.96%) 03/21/23 Largest borrow rate increases among liquid names 03/15/23 Largest borrow rate increases among liquid names 03/08/23 Notable open interest changes for March 8th 02/03/23 Largest borrow rate increases among liquid names
Hot Stocks	KULR Technology appoints Shawn Canter as new FO » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 KULR KULR Technology / + , GS Goldman Sachs $318.50 / -0.09 (-0.03%) KULR Technology (KULR)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KULR GS KULR KULR Technology / + 03/13/23 KULR Technology opens research and development center in Texas 02/07/23 KULR announces issuance of U.S. patent covering Li-Ion battery storage 02/01/23 KULR Technology retains Integrous Communications 01/23/23 KULR Technology CEO says 'time to stand up to naked short selling' GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/28/23 Apple introduces Apple Pay Later, consumers able to pay for purchases over time 03/26/23 Fly Intel: Top five weekend stock stories 03/24/23 Ally Financial names Russell Hutchinson as CFO, effective July 3 03/19/23 Fly Intel: Top five weekend stock stories KULR GS KULR KULR Technology / + GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/24/23 RBC Capital Goldman Sachs price target lowered to $339 from $370 at RBC Capital 03/09/23 BofA Goldman Sachs price target raised to $425 from $384 at BofA 03/02/23 Seaport Global Goldman remains a top pick at Seaport after investor day 03/01/23 Jefferies Jefferies keeps Buy on Goldman Sachs, says 'questions remain' after investor day KULR GS KULR KULR Technology / + 03/23/23 KULR Technology reports Q4 EPS (4c), consensus (5c) GS Goldman Sachs $318.50 / -0.09 (-0.03%) 01/17/23 Goldman Sachs reports Q4 EPS $3.32, consensus $5.48 10/18/22 Goldman Sachs reports Q3 EPS $8.25, consensus $7.69 10/17/22 Notable companies reporting before tomorrow's open 10/17/22 Notable companies reporting before tomorrow's open GS GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/26/23 Banking stress puts U.S., Europe on watch for credit crunch, Reuters says 03/20/23 Goldman tells Reuters Credit Suisse AT1 move could cut long-term demand 03/20/23 Big-bank CEOs discussing capital infusion for First Republic, WSJ says 03/18/23 Biggest banks looking like winners, Barron's says GS GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/16/23 What You Missed On Wall Street This Morning 02/24/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street This Morning 04/18/23 Goldman Sachs - GS 04/26/23 Goldman Sachs Group Inc. GS GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/09/23 World Low Volatility ETF put volume heavy and directionally bearish 01/17/23 Unusually active option classes on open January 17th 12/05/22 World Low Volatility ETF put volume heavy and directionally bearish 10/18/22 Unusually active option classes on open October 18th
Initiation	Tandem Diabetes initiated with a Neutral at UBS » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 TNDM TNDM / + In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly TNDM TNDM / + 03/20/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 03/15/23 Tandem Diabetes announces NEJM publication of study on t:slim X2 insulin pump 03/03/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 02/22/23 Tandem Diabetes names Rebecca Robertson as new board chair TNDM TNDM / + 03/28/23 UBS Tandem Diabetes initiated with a Neutral at UBS 03/07/23 Lake Street Tandem pairing with Abbott sensors can be 'big deal,' says Lake Street 02/23/23 Craig-Hallum Tandem Diabetes price target lowered to $74 from $80 at Craig-Hallum 02/23/23 Piper Sandler Tandem Diabetes price target lowered to $50 from $70 at Piper Sandler TNDM TNDM / + 02/22/23 Tandem Diabetes sees FY23 revenue $885M-$900M, consensus $891.6M 02/22/23 Tandem Diabetes reports Q4 EPS (25c), consensus (6c) 02/22/23 Notable companies reporting after market close 01/10/23 Tandem Diabetes sees FY22 revenue at 'approximately' $805M, consensus $802.5M TNDM TNDM / + 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports TNDM TNDM / + 02/22/23 Fly Intel: After-Hours Movers 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 01/11/23 What You Missed On Wall Street On Wednesday 01/11/23 What You Missed On Wall Street This Morning

Hot Stocks	ProMIS Neurosciences presents in vitro preclinical data on PMN310 » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 PMN ProMIS Neurosciences $4.30 / + (+0.00%) ProMIS Neurosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News PMN ProMIS Neurosciences $4.30 / + (+0.00%) 10/12/22 ProMIS Neurosciences closes $7.4M private placement
Recommendations	Restructuring not positive for growth companies like Lucid, says BofA » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 LCID Lucid Group $7.56 / -0.58 (-7.13%) After Lucid announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LCID Lucid Group $7.56 / -0.58 (-7.13%) 07:33 Today Lucid Group to cut workforce by about 18% as part of restructuring plan 03/28/23 Lucid Group down 6% to $7.64 following report of layoffs 03/27/23 Lucid recalls 2022-2023 Lucid Air vehicles for issue with electric motors 02/22/23 Lucid Group down 8% afterhours at $9.14 after Q4 results and 2023 outlook LCID Lucid Group $7.56 / -0.58 (-7.13%) 08:22 Today Morgan Stanley Other EV startups may need to consider actions like Lucid, says Morgan Stanley 03/02/23 Citi Lucid Group price target lowered to $11.50 from $12 at Citi 02/23/23 R.F. Lafferty Lucid Group price target lowered to $12 from $17 at R.F. Lafferty 02/23/23 Exane BNP Paribas Lucid Group downgraded to Neutral from Outperform at Exane BNP Paribas LCID Lucid Group $7.56 / -0.58 (-7.13%) 02/22/23 Lucid Group reports Q4 EPS (28c), consensus (40c) 02/22/23 Notable companies reporting after market close 11/08/22 Lucid Group reports Q3 EPS (40c), consensus (31c) 11/08/22 Notable companies reporting after market close LCID Lucid Group $7.56 / -0.58 (-7.13%) 03/28/23 Lucid Group to eliminate 18% of workforce, Insider reports 01/30/23 Fuzzy Panda short Lucid Group, calls buyout rumor 'fake news' 01/30/23 Fuzzy Panda says sell Lucid Group on 'fake' buyout rumor 01/27/23 Lucid Group spike attributed to takeout speculation by Betaville LCID Lucid Group $7.56 / -0.58 (-7.13%) 03/28/23 What You Missed On Wall Street On Tuesday 02/27/23 What You Missed This Week in EVs and Clean Energy 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning 04/24/23 Lucid Group Inc LCID Lucid Group $7.56 / -0.58 (-7.13%) 03/21/23 Largest borrow rate increases among liquid names 02/28/23 Largest borrow rate increases among liquid names 02/27/23 Largest borrow rate increases among liquid names 02/22/23 Lucid Group options imply 13.9% move in share price post-earnings
Hot Stocks	CVS Health completes acquisition of Signify Health » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 CVS CVS Health $73.13 / -0.41 (-0.56%) , SGFY Signify Health $30.50 / +0.025 (+0.08%) Under the terms of the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 03/27/23 CVS Health expects to complete Signify Health acquisition around March 29 03/14/23 Senate Democrats urge Walmart, Kroger, others to sell mifepristone 03/06/23 Oscar Health announces renewed agreement with CVS Caremark 02/08/23 CVS Health says Oak Street Health deal has long term growth, earnings power SGFY Signify Health $30.50 / +0.025 (+0.08%) 03/27/23 CVS Health expects to complete Signify Health acquisition around March 29 03/06/23 Cardinal Health, Signify Health collaborate on in-home health management 02/13/23 Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4 01/11/23 Signify Health announces collaboration with Prospect Medical CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 03/21/23 Wolfe Research Oak Street Health downgraded to Peer Perform from Outperform at Wolfe Research 03/15/23 TD Cowen Oak Street Health downgraded to Market Perform from Outperform at TD Cowen 02/15/23 Bernstein Oak Street Health downgraded to Market Perform from Outperform at Bernstein 02/10/23 Raymond James Oak Street Health downgraded to Market Perform from Outperform at Raymond James SGFY Signify Health $30.50 / +0.025 (+0.08%) 11/02/22 B. Riley B. Riley downgrades Semler Scientific on risk from Signify buyout 09/20/22 Piper Sandler Change Healthcare downgraded to Neutral from Overweight at Piper Sandler 09/12/22 William Blair Option Care a 'must-own' in smidcap healthcare services, says William Blair 09/07/22 Evercore ISI CVS Health price target raised to $125 from $120 at Evercore ISI CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 02/08/23 CVS Health sees FY23 revenue $332.7B-$338.5B, consensus $325.11B 02/08/23 CVS Health reports Q4 adjusted EPS $1.99, consensus $1.92 02/08/23 CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00 02/08/23 CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 SGFY Signify Health $30.50 / +0.025 (+0.08%) 01/10/23 CVS Health reaffirms FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 CVS CVS CVS Health $73.13 / -0.41 (-0.56%) 03/08/23 Walgreens stops offer abortion pill in 21 states, face blowback, NYTimes report 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 02/24/23 Sell these stocks now, proven algorithm says 02/08/23 What You Missed On Wall Street On Wednesday 02/08/23 What You Missed On Wall Street This Morning 02/08/23 Fly Intel: Pre-market Movers SGFY Signify Health $30.50 / +0.025 (+0.08%) 02/24/23 Sell these stocks now, proven algorithm says 11/02/22 Semler sinks after results as analyst highlights risk from Signify buyout 04/24/23 RSA Conference 2023 05/03/23 CVS Health - CVS CVS CVS CVS Health $73.13 / -0.41 (-0.56%) 03/15/23 CVS Health put volume heavy and directionally bearish 03/06/23 Unusually active option classes on open March 6th 02/08/23 Early notable gainers among liquid option names on February 8th 02/08/23 Unusually active option classes on open February 8th
Hot Stocks	Aquestive Therapeutics expands license, supply agreement with Pharmanovia » 08:32 03/29/23 03/29 08:32 03/29/23 08:32 AQST Aquestive Therapeutics / + Aquestive Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AQST Aquestive Therapeutics / + 01/06/23 Aquestive Therapeutics provides business update, 2023 objectives 12/22/22 Aquestive Therapeutics completes FDA End-of-Phase 2 meeting for AQST-109 11/29/22 Aquestive Therapeutics announces publication of crossover food effect study 10/27/22 Aquestive licenses Sympazan Oral Film to Assertio AQST Aquestive Therapeutics / + 03/09/23 Wedbush Aquestive Therapeutics upgraded at Wedbush with cash runway extended 03/09/23 Wedbush Aquestive Therapeutics upgraded to Outperform from Neutral at Wedbush 01/31/23 Wedbush Aquestive Therapeutics downgraded to Neutral from Outperform at Wedbush 11/04/22 Alliance Global Partners Aquestive price target lowered to $7 from $10 at Alliance Global Partners AQST Aquestive Therapeutics / + 03/07/23 Aquestive Therapeutics sees FY23 revenue $37M-$41M, consensus $37.83M 03/07/23 Aquestive Therapeutics reports Q4 EPS (23c), consensus (23c)
Hot Stocks	VirnetX enters non-exclusive sales agreement with Solution Synergy » 08:31 03/29/23 03/29 08:31 03/29/23 08:31 VHC VirnetX $1.71 / +0.03 (+1.79%) VirnetX announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

BOSC
Today at 09:00

BOS Better Online Solutions - BOSC Conference Calls
IBEX
Today at 09:00

Ibex - IBEX Conference Calls
UNF
Today at 09:00

UniFirst - UNF Conference Calls
RDW
Today at 09:00

Redwire - RDW Conference Calls
CLH
Today at 09:00

Clean Harbors Firm Sponsored Meetings

Virtual Meeting
PAYX
Today at 09:30

Paychex - PAYX Conference Calls
RMR
Today at 09:30

The RMR Group Inc. Firm Sponsored Meetings
Today at 10:00

Pending Home Sales Index: February 2023 Government Event
Today at 10:00

State Street Investor Confidence Index: March 2023 Government Event
Today at 10:00

Joint Committee Meeting Government Event

Teleconference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Jefferies aerospace/defense analysts to hold analyst/industry conference call

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access